FDA Approval Activities for this Drug…

VIRAMUNE (nevirapine) Tablets and Suspension, Boehringer Ingleheim NDA 20-636/S20 & 20-933/S10 7/29/03 8/6/03 8/6/03 VIRAMUNE (nevirapine) Tablets and Suspension, Boehringer Ingleheim NDA 20-636/S-016 & 20-933/S-006 12/31/02 1/29/03 4/3/03 Viramune (Nevirapine) Tablets & Solution, Boehringer Ingelheim NDA 20-636/S17 & 20-933/S7 VIRAMUNE (nevirapine) Suspension, Boehringer Ingleheim Pharmaceuticals VIRAMUNE (nevirapine) Tablets, Boehringer Ingleheim Pharmaceuticals | Lamivudine/Zidovudine Tablets co-packaged w/Nevirapine Tablets, Pharmacare Limited, Tentative Approval | Viramune (nevirapine) tablets, Boehringer Ingelheim Pharma, Labeling Revision | Viramune (nevirapine) oral suspension, Boehringer Ingelheim Pharma, Labeling Revision

For the latest approval information, please see the main page.